Incyte Corp reports results for the quarter ended June 30 - Earnings Summary

Incyte

28/07/2026 13:48

Incyte Corp INCY.OQ reported quarterly adjusted earnings of $3.09​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $1.57.  The mean expectation of twenty three analysts for the quarter was for earnings of $2.10 per share. Wall Street expected results to range from $1.63  to $2.85 per share.
Revenue rose 37.7% to $1.67 billion from a year ago; analysts expected $1.47 billion. 
Incyte Corp's reported EPS for the quarter was $2.81​.
The company reported quarterly net income of $585.61 million.
Incyte Corp shares had risen by 4.9% this quarter and gained 20.4% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 15% in the last three months.​ 
In the last 30 days, two analysts negatively revised earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy," 15 "hold" and no "sell" or "strong sell." The average consensus recommendation for the pharmaceuticals peer group is also "buy" 
Wall Street's median 12-month price target for Incyte Corp is $112.00, about 6.1% below its last closing price of $118.87
This summary was machine generated from LSEG data July 28 at 12:48 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
2.10
3.09
Beat
Mar. 31 2026 
1.37
1.81
Beat
Dec. 31 2025 
1.93
1.80
Missed
Sep. 30 2025 
1.66
2.26
Beat